Photodynamic therapy
Photodynamic therapy is a new form of treatment for disorders and cosmetic indications caused by fast-growing diseased cells or bacteria. With this particular treatment, a light-activated drug (photosensitizer) is either administered locally to target the affected tissue or intravenously to the affected organ. The photosensitizer concentrates to varying degrees in different tissue and cell types and accumulates in fast-growing structures. The photosensitizer only becomes effective when it is activated by (laser) light. The light is applied either from outside or endoscopically via fiber optic wave guides.

The exact siting of the treatment is determined and monitored through the selective concentration of the photosensitizer and a local light source. This means that PDT has relatively few side effects, unlike chemotherapy, for example.

Photodynamic therapy from biolitec AG is based upon three key components:

  • Phototherapeutic products from biolitec are based on PChl (photochlorine) and Bpheo (Bacteriopheophorbides), which are obtained from algae and bacteria and are available in a highly pure form. The reaction of these substances is triggered by exposure to red light.
  • PhotoSelect is a phototherapy using a low light power, so there is no thermal damage. Convenient diode lasers in the 650 nm to 760 nm range are used. The wavelength of the laser used is that which is absorbed by the phototherapeutic products and cause their activation.
  • Different laser delivery systems are used to apply the laser light, depending on the application and the organ concerned. Microlenses, cylinder spots and balloons are used.

Find out more about biolitec and PDT – download our biolitec magazine

 
Petrakis Holdings Ltd: 18 Lysimachou, Ayia Fyla 3117, P.O.Box: 53430, Limassol 3302, Cyprus.
Tel.: +357 25388868, Fax: +357 25388940
e-mail:
tradelin@spidernet.com.cy